Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 19, 2019

Transgene receives MHRA approval for clinical trial of next-generation oncolytic virus

Transgene has received the approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with a Phase 1/2a clinical trial of TG6002 administered by intrahepatic artery (IHA) infusion in colorectal cancer patients with unresectable liver metastases (CRLM).

Transgene receives MHRA approval for clinical trial of next-generation oncolytic virus